A pioneering gene therapy has shown promising results in restoring sight in young children with AIPL1-associated severe retinal dystrophy—an ultra-rare genetic condition that causes profound sight impairment from birth and, until now, had no existing treatment. The findings, published in The Lancet, mark a major step forward in tackling inherited blindness.

This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.

In this letter, Mr Wagih Aclimandos, President of the European Society of Ophthalmology (SOE) and Consultant Ophthalmic Surgeon and Lead Clinician for Paediatric Ophthalmology and Strabismus Services at King’s College Hospital, London, shares his insights and highlights of what ...

The FDA has accepted an NDA for SYD-101, a proprietary low-dose atropine formulation developed to slow paediatric myopia progression. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of October 23, 2025.

The International Congenital Corneal Opacification Network (ICCON) is a pioneering initiative dedicated to improving the care and management of children with congenital corneal opacities worldwide. Established by the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) in collaboration with the Paediatric Keratoplasty Association (PKA), ICCON aims to connect specialists, surgeons, and healthcare professionals with a shared mission: ensuring that children with these rare yet challenging conditions receive the expertise and treatment they need.

This year, we are celebrating our inaugural touchOPHTHALMOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform ophthalmology in the years to come.

In this Q&A, Dr Zhu shares the personal and professional influences that shaped her journey, her excitement for the future of ophthalmology, and her advice for aspiring medical professionals looking to enter the field.

In this Q&A, he shares insights into his career journey, the experiences that shaped his path and what excites him most about the future of ophthalmology.

In this Q&A, Dr Cicinelli shares her inspirations, career journey and insights into the future of ophthalmology and where she plans to make her mark.